LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article: La doxycycline ou comment faire du neuf avec du vieux ?

Shehwaro, Nathalie / Langlois, Anne-Lyse / Gueutin, Victor / Gauthier, Marion / Casenave, Maud / Izzedine, Hassane

Therapie

2014  Volume 69, Issue 2, Page(s) 129–141

Abstract: Tetracyclines are broad-spectrum antibiotics that interfere with protein synthesis. They were first widely prescribed by dermatologists in the early 1950s in the treatment of acne. More recently, their biological actions on inflammation, proteolysis, ... ...

Title translation Doxycycline or how to create new with the old?.
Abstract Tetracyclines are broad-spectrum antibiotics that interfere with protein synthesis. They were first widely prescribed by dermatologists in the early 1950s in the treatment of acne. More recently, their biological actions on inflammation, proteolysis, angiogenesis, apoptosis, metal chelation, ionophoresis, and bone metabolism were studied. Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes that degrade components of the extracellular matrix (ECM). MMPs have direct or indirect effects on the vascular endothelium and the vascular relaxation/contraction system. The therapeutic effects of tetracyclines and analogues were studied in rosacea, bullous dermatoses, neutrophilic diseases, pyoderma gangrenosum, sarcoidosis, aortic aneurysms, cancer metastasis, periodontitis and autoimmune diseases autoimmune diseases such as rheumatoid arthritis and scleroderma. In addition, downregulation of MMP using doxycycline could be beneficial in reducing vascular dysfunction mediated by MMPs and progressive damage of the vascular wall. We review the nonantibiotic properties of doxycycline and its potential clinical applications.
MeSH term(s) Animals ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Anti-Inflammatory Agents/therapeutic use ; Doxycycline/pharmacology ; Doxycycline/therapeutic use ; Drug Repositioning ; Humans ; Matrix Metalloproteinase Inhibitors/pharmacology ; Matrix Metalloproteinase Inhibitors/therapeutic use ; Matrix Metalloproteinases/metabolism ; Neoplasms/drug therapy ; Neoplasms/pathology ; Periodontal Diseases/drug therapy ; Rheumatic Diseases/drug therapy ; Skin Diseases/drug therapy
Chemical Substances Anti-Bacterial Agents ; Anti-Inflammatory Agents ; Matrix Metalloproteinase Inhibitors ; Matrix Metalloproteinases (EC 3.4.24.-) ; Doxycycline (N12000U13O)
Language French
Publishing date 2014-03
Publishing country France
Document type English Abstract ; Journal Article ; Review
ZDB-ID 603474-3
ISSN 1958-5578 ; 0040-5957
ISSN (online) 1958-5578
ISSN 0040-5957
DOI 10.2515/therapie/2013069
Shelf mark
Ue I Zs.272: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top